San Luis Wealth Advisors LLC Halozyme Therapeutics, Inc. Transaction History

San Luis Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$37.35 - $48.3 $33,017 - $42,697	-884 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$31.97 - $41.06 $28,261 - $36,297	884 New	884 $36,000
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $279,093 - $357,418	-8,771 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$38.47 - $46.42 $337,420 - $407,149	8,771 New	8,771 $357,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of San Luis Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on San Luis Wealth Advisors LLC with notifications on news.